Francillard, Nathalie

Ruxolitinib in polycythemia vera: Follow-up from the RESPONSE trial.

Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 7087-7087

10.1200/jco.2015.33.15_suppl.7087